Evaluating bone defect repairs using human stem cells: NeoStem, University of Michigan enter into SRA
Evaluating bone defect repairs using human stem cells: NeoStem, University of Michigan enter into SRA
NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced today that it has entered into a sponsored research agreement (SRA) with the University of Michigan to evaluate bone defect repairs using human stem cells. The one-year project, beginning in March, will be funded through the proceeds of a $108,746 grant from the National Institutes of …
Read more on News-Medical-Net